National Drug Code (NDC) Database
-
NDC:
43798-014
-
Nonproprietary Name:
Lumacaftor/Ivacaftor Paediatric
-
Dosage Form:
TABLET, FILM COATED
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
125; 100 mg/1; mg/1
-
Substance:
IVACAFTOR; LUMACAFTOR
-
Start Marketing Date:
2017-11-29
-
End Marketing Date:
2026-10-31
-
DEA Schedule:
-
Certified Through:
0000-00-00
AGC Biologics A/S
-
NDC:
82507-004
-
Nonproprietary Name:
Ustekinumab
-
Dosage Form:
SOLUTION
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
90 g/L
-
Substance:
USTEKINUMAB
-
Start Marketing Date:
2024-07-04
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
AGC Biologics, Inc.
-
NDC:
83277-005
-
Nonproprietary Name:
AXATILIMAB
-
Dosage Form:
SOLUTION
-
Product Type:
DRUG FOR FURTHER PROCESSING
-
Strength:
50 mg/mL
-
Substance:
AXATILIMAB
-
Start Marketing Date:
2024-08-14
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
AGC Inc.
-
NDC:
75872-0001
-
Nonproprietary Name:
Tafluprost
-
Dosage Form:
SOLUTION
-
Product Type:
BULK INGREDIENT
-
Strength:
2 g/2g
-
Substance:
TAFLUPROST
-
Start Marketing Date:
2011-06-15
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
AGC Pharma Chemicals Europe, S.L.U.
-
NDC:
65404-010
-
Nonproprietary Name:
Taletrectinib adipate
-
Dosage Form:
POWDER
-
Product Type:
BULK INGREDIENT
-
Strength:
1 kg/kg
-
Substance:
TALETRECTINIB ADIPATE
-
Start Marketing Date:
2026-06-01
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2027-12-31
AGC WAKASA CHEMICALS CO., LTD.
-
NDC:
70390-0001
-
Nonproprietary Name:
Tafluprost
-
Dosage Form:
SOLUTION
-
Product Type:
BULK INGREDIENT
-
Strength:
2 g/2g
-
Substance:
TAFLUPROST
-
Start Marketing Date:
2019-10-01
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
AGC, Inc.
-
NDC:
75872-0002
-
Nonproprietary Name:
Perfluorhexlyoctane
-
Dosage Form:
LIQUID
-
Product Type:
BULK INGREDIENT
-
Strength:
200 kg/200kg
-
Substance:
PERFLUOROHEXYLOCTANE
-
Start Marketing Date:
2023-01-01
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Agilent Technologies Inc.
-
NDC:
70596-1007
-
Nonproprietary Name:
Plozasiran
-
Dosage Form:
INJECTION
-
Product Type:
BULK INGREDIENT
-
Strength:
1 g/g
-
Substance:
PLOZASIRAN SODIUM
-
Start Marketing Date:
2025-11-18
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2027-12-31
Agilent Technologies, Inc.
-
NDC:
70596-1004
-
Nonproprietary Name:
vutrisiran sodium
-
Dosage Form:
POWDER
-
Product Type:
BULK INGREDIENT
-
Strength:
1 g/g
-
Substance:
VUTRISIRAN
-
Start Marketing Date:
2022-06-14
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
-
NDC:
72568-000
-
Nonproprietary Name:
MENTHOL
-
Dosage Form:
CRYSTAL
-
Product Type:
BULK INGREDIENT
-
Strength:
1 kg/kg
-
Substance:
MENTHOL
-
Start Marketing Date:
2018-11-01
-
End Marketing Date:
0000-00-00
-
DEA Schedule:
-
Certified Through:
2026-12-31
Create a New Buying Request
Fields marked with * are mandatory.